Good news, kind of. New data from the Centers for Disease Control and Prevention indicate that the United States reversed a three-year decline in life expectancy in 2018, thanks to gains made in combating opioid deaths and to improved cancer treatment. But before we cheer too loudly, a longer view is necessary. The 2018 number is still below where we were in 2014 and continues a pattern of progressively poorer performance relative to other countries dating back to 1980, even as our health care costs eclipsed them.
In this context, a very public health-care-industry spat about the unbalanced health care system in Colorado is worth noting. Officials there are pointing to the paltry amounts spent on primary care—the only health service where an increase in supply has been associated with longer life expectancy—while calling the hospital industry to account for high prices and large profits. It is a louder version of discussions happening elsewhere.